Dacomitinib
Dacomitinib (PF-00299804, PF-299804) is a potent, irreversible, orally active pan-ErbB receptor tyrosine kinase inhibitor with IC50 of 6, 45.7 and 73.7 for EGFR, ERBB2 and ERBB4, respectively.
Product Specifications
CAS Number
1110813-31-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
469.9
Molecular Formula
C24H25ClFN5O2
Notes
Research use only, not for human use.
Receptor
EGFR|HER2/ErbB2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog